Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Enteric Disease Testing Market, by End User
1.4.2 North America Enteric Disease Testing Market, by Disease Type
1.4.3 North America Enteric Disease Testing Market, by Product Type
1.4.4 North America Enteric Disease Testing Market, by Technique
1.4.5 North America Enteric Disease Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. North America Enteric Disease Testing Market by End User
4.1 North America Hospital Laboratories Market by Country
4.2 North America Pharmaceutical & Biotechnology Companies Market by Country
4.3 North America Academic & Research Institutes Market by Country
Chapter 5. North America Enteric Disease Testing Market by Disease Type
5.1 North America Bacterial Market by Country
5.2 North America Viral Market by Country
5.3 North America Parasitic Market by Country
Chapter 6. North America Enteric Disease Testing Market by Product Type
6.1 North America Reagents & Consumables Market by Country
6.2 North America Equipment Market by Country
Chapter 7. North America Enteric Disease Testing Market by Technique
7.1 North America Immunodiagnostics Market by Country
7.2 North America Molecular Diagnostics Market by Country
Chapter 8. North America Enteric Disease Testing Market by Country
8.1 US Enteric Disease Testing Market
8.1.1 US Enteric Disease Testing Market by End User
8.1.2 US Enteric Disease Testing Market by Disease Type
8.1.3 US Enteric Disease Testing Market by Product Type
8.1.4 US Enteric Disease Testing Market by Technique
8.2 Canada Enteric Disease Testing Market
8.2.1 Canada Enteric Disease Testing Market by End User
8.2.2 Canada Enteric Disease Testing Market by Disease Type
8.2.3 Canada Enteric Disease Testing Market by Product Type
8.2.4 Canada Enteric Disease Testing Market by Technique
8.3 Mexico Enteric Disease Testing Market
8.3.1 Mexico Enteric Disease Testing Market by End User
8.3.2 Mexico Enteric Disease Testing Market by Disease Type
8.3.3 Mexico Enteric Disease Testing Market by Product Type
8.3.4 Mexico Enteric Disease Testing Market by Technique
8.4 Rest of North America Enteric Disease Testing Market
8.4.1 Rest of North America Enteric Disease Testing Market by End User
8.4.2 Rest of North America Enteric Disease Testing Market by Disease Type
8.4.3 Rest of North America Enteric Disease Testing Market by Product Type
8.4.4 Rest of North America Enteric Disease Testing Market by Technique
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Becton, Dickinson and Company
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Neogen Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Bureau Veritas S.A.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.5 SGS S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.6 Eurofins Scientific SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Acquisition and Mergers:
9.7 Merck KGaA
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 PerkinElmer, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Intertek Group PLC
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.10. TÜV Nord Group
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
Unique Offerings 